Immunic Inc (IMUX) is lower by 5.93% Tuesday In Premarket Trading

Immunic Inc (IMUX) is lower by Tuesday morning, with the stock declining -5.93% in pre-market trading to 1.11. IMUX's short-term technical score of 45 indicates that the stock has traded less bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 129 out of 146 industries, IMUX ranks higher than 63% of stocks. Immunic Inc has fallen 24.36% over the past month, closing at $1.37 on October 10. During this period of time, the stock fell as low as $1.01 and as high as $1.92. IMUX has an average analyst recommendation of Strong Buy. The company has an average price target of $13.75.

IMUX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on IMUX!

See Full IMUX Report

Immunic Inc has a Long-Term Technical rank of 29. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 71% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, IMUX ranks better than 130% of stocks.

Important Dates for Investors in IMUX:

-Immunic Inc is set to release earnings on 2024-01-31. Over the last 12 months, the company has reported EPS of $-3.44. -We do not have a set dividend date for Immunic Inc at this time. Click Here To Get The Full Report on Immunic Inc (IMUX)